What type of study is this?

This is a Cross-Sectional Study study (also classified as: Quantitative Study).

September 16, 2025European PsychiatryOpen Access

Apathy, Beta-amyloid Burden and Cognitive Decline in Parkinson’s Disease Patients

View Full Paper

Ask AI

Bookmark

Authors

RFRosario Fernández-FernándezInstituto de Investigación Biosanitaria de Granada RRRafael Rodríguez‐RojasInstituto de Salud Carlos III CTClara TrompetaUniversidad de Alcalá

Discussion

Member takes

Implication

This analysis reveals that increased beta-amyloid burden in apathetic Parkinson’s patients worsens cognitive decline, indicating significant implications for treatment.

Key Points

Patients with apathy showed a higher rate of progression to dementia or mild cognitive impairment within three years.
Apathetic Parkinson’s disease patients had significantly poorer performance in key neuropsychological tests related to memory and attention.
Imaging analysis indicated greater beta-amyloid deposition in apathetic patients compared to non-apathetic peers.
Differences in disease duration were noted in clinical comparisons between apathetic and non-apathetic patients.

Cite This Study

Fernández-Fernández et al. (2025) studied this question.

synapsesocial.com/papers/68d4507331b076d99fa57bc1 https://doi.org/10.1192/j.eurpsy.2025.1664

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals that increased beta-amyloid burden in apathetic Parkinson’s patients worsens cognitive decline, indicating significant implications for treatment.

Apathy, Beta-amyloid Burden and Cognitive Decline in Parkinson’s Disease Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Apathy, Beta-amyloid Burden and Cognitive Decline in Parkinson’s Disease Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider